Explore over 1000 Cell & Gene therapies from more than 300 companies including Biopharma, Big Pharma, CMOs and Research Academic Institutes across multiple therapeutic areas of focus in Asia-Pacific region. This unique data gives you access to broad coverage of both Cell & Gene Therapy Pipeline and Manufacturing, in a single platform. It tracks Cell & Gene Therapy market from over 11 APAC countries including South-Korea, Japan, China, Taiwan, India, Australia, Singapore, Malaysia, Indonesia, Thailand and Hong-Kong among others.
The data is covered across several parameters to provide real-time insights into cell & gene therapy industry such as the list of APAC based CGT companies, cell therapy products, gene therapies, viral & non-viral therapies, allogenic vs autologous therapies, cell & gene therapy pipelines across all stages of development, route of administration for drug candidates and targets, indications, technology platform used in the development, manufacturing of cell and gene therapy products, clinical and commercial production, in-house manufacturing capabilities of cell and gene therapy companies, clinical trial projects, cell and gene therapy manufacturing facilities, production capacity, upstream and downstream processing capabilities, cell therapy processing equipment and technologies and other detailed information on cell and gene therapy developers and manufacturers.
Examples of CGT companies included in this data are top pharmaceutical companies such as Novartis AG, Gilead Sciences, JCR Pharmaceuticals and other biopharmaceutical companies including Kolon Life Sciences, Medipost, Curocell, Anges MG, Anterogen, X-Cell therapeutics and many others. Some of the research and academic institutes covered in this tracker are Biostar Stem Cell Research Institute, Chiba University, National Cancer Center in Japan and Peking University in addition to CDMO/CMOs including XCell Therapeutics, Lonza, Bora Pharmaceuticals, Cell Therapeutics Ltd and other top cell & gene therapy manufacturers in the APAC region.
The data is underpinned by user-friendly visuals to allow users to filter through data by cell and gene therapy company, country, product type, cell therapy types, viral vectors types, scale of stage of development, therapy focus area, company founded year, type of company, manufacturing facility location, facility size range, expression system, batch/continuous process, bioreactor type facility operational year, batch size of products and facility counts in a particular APAC country.